Long-term outcome of interstitial lung disease in patients with primary Sjögren's syndrome: a retrospective observational study
Jung Hee Koh, Youngjae Park, Jennifer Lee, Howook Jeon, Su-Jin Moon, Yong Hyun Kim, Jun-Ki Min, Sung-Hwan Park, Seung-Ki Kwok
Korean J Intern Med. 2025;40(1):148-159. Published online 2024 Oct 25 DOI: https://doi.org/10.3904/kjim.2023.402
Citations to this article as recorded by 
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational “EMERGE” study
Andreina Manfredi, Caterina Vacchi, Stefania Cerri, Roberta Eufrasia Ledda, Roberto D'Amico, Fabrizio Luppi, Fabrizio Pancaldi, Giulia Cassone, Alessandra Rai, Dario Andrisani, Filippo Gozzi, Giovanni Della Casa, Lucia Dardani, Fabiola Atzeni, Athina Pats
Seminars in Arthritis and Rheumatism.2026; 76: 152886. CrossRef
Chest muscle area, spleen density, CD4 + T%, and C4 to predict the development of interstitial lung disease in patients with Sjögren’s syndrome: a clinical prediction model
Wenpeng Ge, Changhua Liang, Zhixia Wang, Chenhuan Fan, Zhenqiang Li, Chaonan Chen, Limin Jing, Zhenzhen Liang
Clinical Rheumatology.2026; 45(3): 1741. CrossRef
mTOR signaling pathway in primary Sjögren's syndrome: Pathogenesis and potential therapeutic targets (Review)
Rongxiu Huo, Yanting Yang, Chengcheng Wei, Yang Yang, Danli Meng, Jinying Lin, Xinxiang Huang
International Journal of Molecular Medicine.2026; 57(4): 1. CrossRef